Ad Astra Diagnostics Files 510(k) for Hematology Analyzer System
Ad Astra Diagnostics submitted a 510(k) application to the FDA for its QScout RLD rapid-result hematology system.
Read MorePosted by Andy Lundin | Apr 3, 2023 | Hematology Instrumentation |
Ad Astra Diagnostics submitted a 510(k) application to the FDA for its QScout RLD rapid-result hematology system.
Read MorePosted by Andy Lundin | Mar 22, 2023 | Cancer |
A co-location model for cancer diagnostic services reported a reduction in the time it took to diagnose cancer at a community health center.
Read MorePosted by Andy Lundin | Mar 14, 2023 | Hematology & Serology |
Siemens Healthineers and Sysmex will provide hemostasis products on an OEM basis, used in testing for blood clotting disorders and more.
Read MorePosted by Andy Lundin | Mar 13, 2023 | Hematology & Serology, Tuberculosis |
A research team discovered new technology that will quickly and easily detect active Mycobacterium tuberculosis (TB) infection antibodies.
Read MorePosted by Andy Lundin | Mar 10, 2023 | Leukemia |
QIAGEN and Servier are partnering to develop a CDx test for TIBSOVO, an isocitrate dehydrogenase-1 inhibitor indicated for AML treatment.
Read More